Delivery Order SPE2DB24D1205-SPE2DB25FCYZE
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,738.42 on August 5, 2025, for the supply of Tamsulosin HCL 0.4 mg capsules (1,000 count). This award is non-competitive and carries a firm fixed price structure with completion targeted for August 6, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, with a ceiling value of $18,084.60. This is a firm fixed-price delivery order with no set-aside designation, meaning the contract was awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen Drug Corp's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1,...
- The Defense Logistics Agency awarded a delivery order valued at $2,609.16 to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, with delivery expected by July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value pharmaceutical procurement supporting military healthcare supply needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, with a contract ceiling value of $1,727.65. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and scheduled for completion by August 8, 2025. The award represents a routine pharmaceutical supply transaction supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,613.70 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg. This contract employs a firm fixed price delivery order structure with no set-aside designation, indicating competitive award. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg at a ceiling value of $2,520.50. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a common medication used to treat benign prostatic hyperplasia. This firm fixed-price delivery order, valued at $11,771.03, is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procedures with no...
- The Defense Logistics Agency awarded a $4,573.03 delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, with a completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child award under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Tamsulosin HCL 0.4 mg capsules in a quantity of 500 units, with a ceiling value of $2,217.99. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and carries an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules under a firm fixed price contract valued at $2,008.55. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 6, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYZEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,374.62 to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg. This non-competitive delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price pharmaceutical procurement contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive pharmaceutical and medical supply support for military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's receipt of this delivery order reflects its competitive capabilities and established position as a critical pharmaceutical vendor supporting Defense Health Agency and broader federal healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/28/25 |